An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Medicinal Chemistry

• Publication date

  2011-05-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/092986711796150469PMID 21651484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic regulation, physiology, assessment and inhibition of efflux pumps responsible for multi-drug resistant phenotypes of bacterial pathogens

  2011cited by this paper
• Antibacterial activity of some natural products against bacteria expressing a multidrug-resistant phenotype.

  2011cited by this paper
• An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates.

  2011cited by this paper
• Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria.

  2010cited by this paper
• Identification of efflux-mediated multi-drug resistance in bacterial clinical isolates by two simple methods.

  2010cited by this paper
• Kinetic Parameters of Efflux of Penicillins by the Multidrug Efflux Transporter AcrAB-TolC of Escherichia coli

  2010cited by this paper
• Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli

  2010cited by this paper
• Increasing of the Aminoglicosyde Antibiotic Activity Against a Multidrug-Resistant E. coli by Turnera ulmifolia L. and Chlorpromazine

  2010cited by this paper
• RamA, a Member of the AraC/XylS Family, Influences Both Virulence and Efflux in Salmonella enterica Serovar Typhimurium

  2010cited by this paper
• Efflux pumps of gram-negative bacteria, a new target for new molecules.

  2010cited by this paper
• Evaluation of efflux activity of bacteria by a semi-automated fluorometric system.

  2010cited by this paper
• Polymyxins and their novel derivatives.

  2010cited by this paper
• Physiological characterisation of the efflux pump system of antibiotic-susceptible and multidrug-resistant Enterobacter aerogenes.

  2010cited by this paper
• Optimized Nile Red Efflux Assay of AcrAB-TolC Multidrug Efflux System Shows Competition between Substrates

  2010cited by this paper
• Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains.

  2010cited by this paper
• Transcriptome Analysis of Genes Controlled by luxS/Autoinducer-2 in Salmonella enterica Serovar Typhimurium

  2010cited by this paper
• Measuring the activity of active efflux in gram-negative bacteria.

  2010cited by this paper
• Efflux Pumps Are Involved in the Defense of Gram-Negative Bacteria against the Natural Products Isobavachalcone and Diospyrone

  2010cited by this paper
• Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli

  2009cited by this paper
• Geraniol Restores Antibiotic Activities against Multidrug-Resistant Isolates from Gram-Negative Species

  2009cited by this paper
• pH Modulation of Efflux Pump Activity of Multi-Drug Resistant Escherichia coli: Protection During Its Passage and Eventual Colonization of the Colon

  2009cited by this paper
• Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways.

  2009cited by this paper
• The assembled structure of a complete tripartite bacterial multidrug efflux pump

  2009influential reference
• Antibiotics for Emerging Pathogens

  2009cited by this paper
• Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria.

  2009cited by this paper
• New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors

  2009cited by this paper
• Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa.

  2009cited by this paper
• The Global Consequence of Disruption of the AcrAB-TolC Efflux Pump in Salmonella enterica Includes Reduced Expression of SPI-1 and Other Attributes Required To Infect the Host

  2009cited by this paper
• Multidrug resistance in bacteria.

  2009influential reference
• Transitions between closed and open conformations of TolC: the effects of ions in simulations.

  2009cited by this paper
• Mechanisms of RND multidrug efflux pumps.

  2009cited by this paper
• An AcrAB-mediated multidrug-resistant phenotype is maintained following restoration of wild-type activities by efflux pump genes and their regulators.

  2009cited by this paper
• Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli

  2009cited by this paper
• Efflux-Mediated Drug Resistance in Bacteria

  2009influential reference
• Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella.

  2009cited by this paper
• Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems.

  2009cited by this paper
• The clinical consequences of antimicrobial resistance.

  2009cited by this paper
• The changing epidemiology of resistance.

  2009cited by this paper
• Fitness Costs and Stability of a High-Level Ciprofloxacin Resistance Phenotype in Salmonella enterica Serotype Enteritidis: Reduced Infectivity Associated with Decreased Expression of Salmonella Pathogenicity Island 1 Genes

  2009cited by this paper
• A coordinated network of transporters with overlapping specificities provides a robust survival strategy

  2009cited by this paper
• Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter.

  2009cited by this paper
• Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS.

  2009cited by this paper
• Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium.

  2009cited by this paper
• Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.

  2009cited by this paper
• Drug transport mechanism of the AcrB efflux pump.

  2009cited by this paper
• Innate and induced resistance mechanisms of bacterial biofilms.

  2008cited by this paper
• Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens.

  2008cited by this paper
• The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria

  2008cited by this paper
• Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities.

  2008cited by this paper
• RamA Confers Multidrug Resistance in Salmonella enterica via Increased Expression of acrB, Which Is Inhibited by Chlorpromazine

  2008cited by this paper
• Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.

  2008cited by this paper
• The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance.

  2008cited by this paper
• The role of the QseC quorum-sensing sensor kinase in colonization and norepinephrine-enhanced motility of Salmonella enterica serovar Typhimurium.

  2008cited by this paper
• Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics.

  2008cited by this paper
• Multiple Regulatory Pathways Associated with High-Level Ciprofloxacin and Multidrug Resistance in Salmonella enterica Serovar Enteritidis: Involvement of ramA and Other Global Regulators

  2008cited by this paper
• Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease.

  2008cited by this paper
• Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation

  2008cited by this paper
• ramR Mutations Involved in Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar Typhimurium

  2008influential reference
• Multidrug efflux transporter, AcrB--the pumping mechanism.

  2008cited by this paper
• Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.

  2007cited by this paper
• Supplementary materials for : Engineered disulfide bonds support the functional rotation mechanism of multidrug efflux pump AcrB

  2007cited by this paper
• Phytochemicals for Bacterial Resistance - Strengths, Weaknesses and Opportunities

  2007cited by this paper
• RamA, a Transcriptional Regulator, and AcrAB, an RND-Type Efflux Pump, are Associated with Decreased Susceptibility to Tigecycline in Enterobacter cloacae

  2007cited by this paper
• Efflux pumps as antimicrobial resistance mechanisms

  2007cited by this paper
• Bacterial efflux pump inhibitors from natural sources.

  2007cited by this paper
• Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

  2007cited by this paper
• Control of Quorum Sensing by a Burkholderia pseudomallei Multidrug Efflux Pump

  2007cited by this paper
• Measuring the impact of multidrug resistance in nosocomial infection

  2007cited by this paper
• Molecular mechanisms of antibacterial multidrug resistance.

  2007cited by this paper
• Implication of Quorum Sensing in Salmonella enterica Serovar Typhimurium Virulence: the luxS Gene Is Necessary for Expression of Genes in Pathogenicity Island 1

  2007cited by this paper
• Drug Export Pathway of Multidrug Exporter AcrB Revealed by DARPin Inhibitors

  2006cited by this paper
• Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump Mechanism

  2006cited by this paper
• MarA-mediated Transcriptional Repression of the rob Promoter*

  2006cited by this paper
• Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other Antimicrobials

  2006cited by this paper
• Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.

  2006cited by this paper
• Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies.

  2006cited by this paper
• Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

  2006cited by this paper
• Multiple regulators of the Flavohaemoglobin (hmp) gene of Salmonella enterica serovar Typhimurium include RamA, a transcriptional regulator conferring the multidrug resistance phenotype

  2006cited by this paper
• Synergistic Interaction between Phenothiazines and Antimicrobial Agents against Burkholderia pseudomallei

  2006cited by this paper
• Quorum sensing in Escherichia coli and Salmonella.

  2006cited by this paper
• Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria

  2006influential reference
• Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates.

  2006cited by this paper
• Prospects for plant-derived antibacterials

  2006cited by this paper
• Multidrug-resistance efflux pumps ? not just for resistance

  2006cited by this paper
• Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli.

  2006cited by this paper
• The fimYZ Genes Regulate Salmonella enterica Serovar Typhimurium Invasion in Addition to Type 1 Fimbrial Expression and Bacterial Motility

  2005cited by this paper
• Constitutive soxR Mutations Contribute to Multiple-Antibiotic Resistance in Clinical Escherichia coli Isolates

  2005cited by this paper
• Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments.

  2005cited by this paper
• Inducement and Reversal of Tetracycline Resistance in Escherichia coli K-12 and Expression of Proton Gradient-Dependent Multidrug Efflux Pump Genes

  2005cited by this paper
• Use of an Efflux Pump Inhibitor To Determine the Prevalence of Efflux Pump-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa

  2005cited by this paper
• Molecular Basis of Azithromycin-Resistant Pseudomonas aeruginosa Biofilms

  2005cited by this paper
• Inhibitors of efflux pumps in Gram-negative bacteria.

  2005cited by this paper
• Selected Arylpiperazines Are Capable of Reversing Multidrug Resistance in Escherichia coli Overexpressing RND Efflux Pumps

  2005cited by this paper
• Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in Klebsiella pneumoniae

  2005cited by this paper
• Inhibitors of Antibiotic Efflux in Resistant Enterobacter aerogenes and Klebsiella pneumoniae Strains

  2004cited by this paper
• Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella typhimurium.

  2004cited by this paper
• Escherichia coli 0157:H7: an update on intestinal colonization and virulence mechanisms.

  2004cited by this paper
• Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204.

  2004cited by this paper
• Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium.

  2004cited by this paper
• Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica Serovar Typhimurium: Role in Multiple Antibiotic Resistance

  2004cited by this paper

• Efflux systems driving resistance and virulence across biological domains

  2025cites this paper
• Contribution of efflux and mutations in fluoroquinolone susceptibility in MDR enterobacterial isolates: a quantitative and molecular study.

  2023cites this paper
• Biochemical Basis of the Antimicrobial Activity of Quinazolinone Derivatives in the Light of Insights into the Features of the Chemical Structure and Ways of Binding to Target Molecules. A Review

  2023cites this paper
• Impeding efflux-mediated resistance in Staphylococcus aureus

  2022cites this paper
• NorA, Tet(K), MepA, and MsrA efflux pumps in Staphylococcus aureus, their inhibitors and 1,8-naphthyridine sulfonamides.

  2022cites this paper
• Multidrug Efflux Pumps in Bacteria and Efflux Pump Inhibitors

  2022cites this paper
• Multidrug Efflux Pumps in Bacteria and Efflux Pump Inhibitors

  2022cites this paper
• Efflux-Mediated bile Resistance in Gram-Positive Pathogens

  2022cites this paper
• Chemical synthesis, molecular docking and MepA efflux pump inhibitory effect by 1,8-naphthyridines sulfonamides.

  2021cites this paper
• Flavonoids as Inhibitors of Bacterial Efflux Pumps

  2021cites this paper
• An Introduction to Bacterial Efflux Pump Inhibitor (EPI) and Analytical Methods for Studying Efflux Pump Inhibitors for Drug Development

  2021cites this paper
• An Update on Staphylococcus aureus NorA Efflux Pump Inhibitors.

  2020cites this paper
• SYNTHESIS, CHARACTERIZATION AND ANTI-BACTERIAL STUDIES OF SOME CYCLIC PEPTIDE DERIVATIVES

  2020cites this paper
• Fibrous Materials for Antimicrobial Applications

  2020cites this paper
• A novel mechanism of action of ketoconazole: inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus

  2019cites this paper
• Meeting the discovery challenge of drug-resistant infections: progress and focusing resources.

  2019cites this paper
• Salmonella enterica Serovar Typhi in Bangladesh: Exploration of Genomic Diversity and Antimicrobial Resistance

  2018cites this paper
• Native efflux pumps of Escherichia coli responsible for short and medium chain alcohol

  2018cites this paper
• Erratum: Unusual marine unicellular symbiosis with the nitrogen-fixing cyanobacterium UCYN-A

  2017cites this paper
• Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation

  2017cites this paper
• Antibacterial activity and modes of action of phosvitin-derived peptide Pt5e against clinical multi-drug resistance bacteria.

  2016cites this paper
• Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.

  2016cites this paper
• Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioidesbrasiliensis

  2016cites this paper
• EXPERIMENTALLY POTENT SYNERGISM RESULTING FROM COMBINATION OF THE ANTIBIOTIC STREPTOMYCIN WITH THE NON-ANTIBIOTIC DICYCLOMINE HYDROCHLORIDE

  2016cites this paper
• Expansion of Shiga Toxin–Producing Escherichia coli by Use of Bovine Antibiotic Growth Promoters

  2016cites this paper
• An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.

  2016cites this paper
• Current Advances in Developing Inhibitors of Bacterial Multidrug 
Efflux Pumps

  2016influential citation
• Antibacterial effects of amino acids-grafted water-soluble chitosan against drug-resistant bacteria

  2016cites this paper
• Antimicrobial Drug Efflux Pumps in Enterobacter and Klebsiella

  2016cites this paper
• Efflux as a Glutaraldehyde Resistance Mechanism in Pseudomonas fluorescens and Pseudomonas aeruginosa Biofilms

  2015cites this paper
• The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria

  2015cites this paper
• Antimicrobial Action of Water-Soluble β-Chitosan against Clinical Multi-Drug Resistant Bacteria

  2015cites this paper
• Role of the culture medium in porin expression and piperacillin-tazobactam susceptibility in Escherichia coli.

  2015cites this paper
• Efflux as a Glutaraldehyde Resistance Mechanism in Pseudomonas fluorescens and Pseudomonas aeruginosa Biofilms

  2015cites this paper
• Mechanisms by which thioridazine in combination with antibiotics cures extensively drug-resistant infections of pulmonary tuberculosis.

  2014cites this paper
• Thioridazine: a potential adjuvant in pharmacotherapy of drug resistant tuberculosis Ki

  2014cites this paper
• Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them

  2014cites this paper
• Membrane transport systems and the biodegradation potential and pathogenicity of genus Rhodococcus

  2014cites this paper
• Bacterial Membrane, a Key for Controlling Drug Influx and Efflux

  2013cites this paper
• Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin.

  2013cites this paper
• A Simple Method for Assessment of MDR Bacteria for Over-Expressed Efflux Pumps

  2013influential citation
• Contribution of different mechanisms to the resistance to fluoroquinolones in clinical isolates of Salmonella enterica

  2013cites this paper
• Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus

  2013cites this paper
• Antibiotics and Resistance: A Fatal Attraction

  2013cites this paper
• Thioridazine: an old neuroleptic effective against totally drug resistant tuberculosis.

  2012cites this paper
• Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds--a critical review.

  2012cites this paper
• Understanding efflux in Gram-negative bacteria: opportunities for drug discovery

  2012cites this paper
• Totally Drug Resistant Tuberculosis can be Treated with Thioridazine in Combination with Antibiotics to which the Patient was Initially Resistant

  2012cites this paper
• Inhibitors of efflux pumps of Gram-negative bacteria inhibit Quorum Sensing

  2012influential citation
• Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis

  2012cites this paper
• Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.

  2012cites this paper
• Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs

  2012cites this paper
• Phenothiazines: Inhibitors of Bacterial Efflux Pumps

  2012cites this paper
• Inhibitors of bacterial efflux pumps that also inhibit efflux pumps of cancer cells.

  2012cites this paper
• Biochemistry & Pharmacology: Open Access

  2012cites this paper
• Antibiotic Transport in Resistant Bacteria: Synchrotron UV Fluorescence Microscopy to Determine Antibiotic Accumulation with Single Cell Resolution

  2012cites this paper
• Evaluation of forty new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains.

  2011cites this paper
• Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol

  2011cites this paper
• Send Orders of Reprints at Reprints@benthamscience.net a Simple Method for Assessment of Mdr Bacteria for Over-expressed Efflux Pumps the Increasing Multi-drug Resistance Reported in Bacterial Clinical Isolates Has Become a Major Concern in the Public

  year unknowncites this paper
• Evidence of significant synergism ^ b-tryt " n antibiotics and the antipsychotic ' anti ; f , ; obial drug flupenthixol

  year unknowncites this paper